Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04822480 · ClinicalTrials.gov registry record
Evaluation of a Telehealth DPP With Medicare Patients at the University of Mississippi Medical Center
A clinical trial of PreDiabetes and Prediabetic State, sponsored by University of Mississippi Medical Center.
- Active
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04822480: Active study of PreDiabetes and Prediabetic State, sponsored by University of Mississippi Medical Center.
NCT04822480 is a study of PreDiabetes and Prediabetic State that is active but no longer recruiting, run by University of Mississippi Medical Center. The registered enrollment target is 500 participants, below the 698-participant average among 149 other PreDiabetes trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04822480, a study of PreDiabetes and Prediabetic State, is active but no longer recruiting, sponsored by University of Mississippi Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The National Diabetes Prevention Program (DPP) is an evidence-based, 12-month lifestyle change program to prevent or delay the onset of type 2 diabetes mellitus (herein referred to as 'diabetes') among adults with prediabetes. The Department of Preventive Medicine, University of Mississippi Medical Center (UMMC), in partnership with the American Medical Association, is collaborating to develop and implement the DPP as a clinical service for UMMC patients beginning in September 2020. We aim to recruit 245 patients per year over 3 years. Because this is the first attempt to develop and implement the DPP as a clinical service at the UMMC, we are proposing to conduct a comprehensive process, outcome, impact and return on investment evaluation. An effectiveness-implementation hybrid research design will be used to (1) evaluate a multifaceted implementation strategy and the effectiveness and impact of the DPP delivered using telehealth by UMMC's Department of Preventive Medicine; (2) conduct an analysis on medical expenditures among those who participate in a DPP to measure net savings and return on investment (ROI) relative to non-participants; (3) conduct a longitudinal cohort analysis to assess incidence of diabetes and changes in body composition, biomarkers, and psycho-social behavioral constructs among those who participate in a DPP relative to those who do not. The findings from this comprehensive research evaluation will be used to (1) improve clinical operations and implementation; (2) demonstrate the cost benefit of the DPP as a clinical service for patients with diabetes risk; and (3) provide empirical support for delivering the DPP via different modalities including telehealth to reduce risk and improve health outcomes among patients.
Conditions Studied
Interventions
- BEHAVIORAL Diabetes Prevention Program (DPP)
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2024-12-31 |
What the registry record for NCT04822480 still lists
NCT04822480 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 698-participant average among 149 other PreDiabetes trials with a reported enrollment target (28% lower).
The record links to 2 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Prevention Program (DPP) is the first listed.
NCT04822480 reports a single indexed study location in Mississippi.
Frequently Asked Questions
What is clinical trial NCT04822480 about?
NCT04822480 is a clinical study titled "Evaluation of a Telehealth DPP With Medicare Patients at the University of Mississippi Medical Center". The National Diabetes Prevention Program (DPP) is an evidence-based, 12-month lifestyle change program to prevent or delay the onset of type 2 diabetes mellitus (herein referred to as 'diabetes') among adults with prediabetes. The Department of Preventive Medicine, University of Mississippi Medical ...
What is the current status of trial NCT04822480?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2020-02-01. Estimated completion is 2024-12-31.
What conditions does trial NCT04822480 study?
This clinical trial studies the following conditions: PreDiabetes, Prediabetic State.
What interventions are being tested in trial NCT04822480?
The interventions under investigation include: Diabetes Prevention Program (DPP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04822480?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04822480 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04822480's enrollment target sits among peer trials
500 17th of 149 higher than 133 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Glucose Variability and Cognition in Prediabetes
RECRUITING
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI